サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553506

生物活性創傷ケアの市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生物活性創傷ケアの市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年08月19日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生物活性創傷ケア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の生物活性創傷ケア市場は、2030年までに184億米ドルに達し、2024年から2030年までのCAGRは7.4％で拡大すると予測されています。

褥瘡、糖尿病性足、その他の皮膚関連感染症などの慢性皮膚疾患の有病率は増加傾向にあります。生物活性創傷ケア製品は、前述の状態を治癒するために効率的に作用する利用可能な治療ラインを提供します。

したがって、対象人口の増加に伴い、生物活性創傷ケア市場は有利な成長を遂げると推定されます。個人衛生に関する患者の意識の高まりが、これらの製品に対する需要を増大させています。意識レベルの向上により、患者は早い段階で医師の助言を求めるようになり、タイムリーな介入が可能になります。

近年、一人当たりのヘルスケア支出が増加し、可処分所得が増加しているため、国民はヘルスケア施設に多額の支出をすることが可能となり、市場の成長に寄与しています。患者に複数の利点を提供する複数の成分を含むコンビネーション創傷被覆材のような高度な製品の開発は、これらの製品の需要を押し上げると予想されます。

生物活性創傷ケア市場のレポートハイライト

  • 湿潤創傷ケアが市場を独占し、2023年には61.1%のシェアを占めました。湿潤創傷被覆材は、適切な水分レベルを維持し、脱水を防ぎ、細胞移動を促進することで最適な治癒環境を作り出し、創傷閉鎖を早めます。
  • 一般外科は、2023年に68.6%と最大の市場収益シェアを占めました。一般外科セグメントはさらに、形成外科、皮膚科、小児科、その他の用途に分類されます。
  • 北米の生物活性創傷ケア市場は、2023年に42.6％の収益シェアで世界の生物活性創傷ケア市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 生物活性創傷ケア市場の変数、動向、範囲

  • 市場イントロダクション / 系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 生物活性創傷ケア市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 生物活性創傷ケア市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 生物活性創傷ケア市場：製品の変動分析、百万米ドル、2023年・2030年
  • 湿潤創傷ケア
  • 抗菌創傷ケア
  • アクティブドレッシング

第5章 生物活性創傷ケア市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 生物活性創傷ケア市場：用途の変動分析、百万米ドル、2023年・2030年
  • 一般外科
  • 低侵襲手術

第6章 生物活性創傷ケア市場：地域の推定・動向分析

  • 生物活性創傷ケア市場シェア、地域別、2023年・2030年、百万米ドル
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • B. Braun SE
    • Essity Health &Medical
    • 3M
    • Convatec Group PLC
    • Covalon Technologies Ltd
    • DermaRite Industries LLC
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Monlnlycke Health Care AB
    • Smith+Nephew
目次
Product Code: GVR-1-68038-081-1

Bioactive Wound Care Market Growth & Trends:

The global bioactive wound care market is expected to reach USD 18.4 billion by 2030 and expanding at a CAGR of 7.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians' advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

Bioactive Wound Care Market Report Highlights:

  • Moist wound care dominated the market and accounted for a share of 61.1% in 2023. Moist wound dressings create an optimal healing environment by maintaining the right moisture level, preventing dehydration, and promoting cell migration for faster closure.
  • General surgery accounted for the largest market revenue share of 68.6% in 2023. The general surgery segment is further classified into plastic, dermatological, pediatric and others applications.
  • North America bioactive wound care market dominated the global bioactive wound care market with a revenue share of 42.6% in 2023, driven by the existence of a substantial number of individuals with diabetes and the quick acceptance of modern wound treatment methods.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioactive Wound Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Moist Wound Care
    • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Foam
        • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Alginate
        • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Film
        • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Hydrocolloid
        • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Hydrogel
        • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Antimicrobial Wound Care
    • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Silver Based
        • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Non-Silver Based
        • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Active Dressing
    • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Biomaterial
        • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. Skin Substituents
        • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 5.3. General Surgery
    • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.1. Plastic
        • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Dermatological
        • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.3. Pediatric
        • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
        • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Minimally Invasive Surgery
    • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

  • 6.1. Bioactive Wound Care Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Essity Health & Medical
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. 3M
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Convatec Group PLC
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Covalon Technologies Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. DermaRite Industries LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hollister Incorporated
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Integra LifeSciences Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Johnson & Johnson Services, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Medtronic
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Monlnlycke Health Care AB
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Smith+Nephew
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives